Key Metrics
Journal Specifications
- PublisherCIG MEDIA GROUP, LP
- LanguageEnglish
- FrequencyBi-monthly
- LanguageEnglish
- FrequencyBi-monthly
- Publication Start Year2010
- Publisher URL
- Website URL
Ready to spotlight your research findings?
Impress peers and journals alike with a concise, visual summary of your work.
Months | % Papers published |
---|---|
0-3 | 76% |
4-6 | 21% |
7-9 | 2% |
>9 | 1% |
Recently Published Papers
Year-wise Publication
- 5Y
- 10Y
FAQs
Since when has Clinical Lymphoma, Myeloma and Leukemia been publishing? 
The Clinical Lymphoma, Myeloma and Leukemia has been publishing since 2010 till date.
How frequently is the Clinical Lymphoma, Myeloma and Leukemia published? 
Clinical Lymphoma, Myeloma and Leukemia is published Bi-monthly.
What is the H-index. SNIP score, Citescore and SJR of Clinical Lymphoma, Myeloma and Leukemia? 
Clinical Lymphoma, Myeloma and Leukemia has a H-index score of 60, Citescore of 3.6, SNIP score of 0.78, & SJR of Q2
Who is the publisher of Clinical Lymphoma, Myeloma and Leukemia? 
The publisher of Clinical Lymphoma, Myeloma and Leukemia is CIG MEDIA GROUP, LP.
How can I view the journal metrics of Clinical Lymphoma, Myeloma and Leukemia on editage? 
For the Clinical Lymphoma, Myeloma and Leukemia metrics, please refer to the section above on the page.
What is the eISSN and pISSN number of Clinical Lymphoma, Myeloma and Leukemia? 
The eISSN number is 2152-2669 and pISSN number is 2152-2650 for Clinical Lymphoma, Myeloma and Leukemia.
Why is it important to find the right journal for my research? 
Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.
Can the choice of journal affect my academic career? 
Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.
Is it advisable to target high-impact journals only? 
While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.